Table 3.
Concomitant therapies
Variables | ELAD
|
Control
|
P-valuea | ||
---|---|---|---|---|---|
n/N | Percentage | n/N | Percentage | ||
| |||||
Patients receiving therapies | |||||
Any concomitant therapy | 15/32 | 46.9 | 6/17 | 35.3 | 0.549 |
Plasma exchange | 11/32 | 34.4 | 5/17 | 29.4 | 1.000 |
Plasma bilirubin absorption | 5/32 | 15.6 | 3/17 | 17.6 | 1.000 |
Continuous blood filtration | 3/32 | 9.4 | 1/17 | 5.9 | 1.000 |
Note:
P-values determined using Fisher’s exact test.